KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Supernus Pharmaceuticals (SUPN) Receivables - Net (2016 - 2026)

Supernus Pharmaceuticals has reported Receivables - Net over the past 15 years, most recently at $187.8 million for Q4 2025.

  • Quarterly Receivables - Net rose 32.18% to $187.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $187.8 million through Dec 2025, up 32.18% year-over-year, with the annual reading at $187.8 million for FY2025, 32.18% up from the prior year.
  • Receivables - Net was $187.8 million for Q4 2025 at Supernus Pharmaceuticals, up from $171.3 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $187.8 million in Q4 2025 and troughed at $127.1 million in Q1 2021.
  • The 5-year median for Receivables - Net is $145.3 million (2022), against an average of $149.0 million.
  • Year-over-year, Receivables - Net decreased 13.61% in 2023 and then surged 32.18% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $148.9 million in 2021, then grew by 11.12% to $165.5 million in 2022, then dropped by 12.9% to $144.2 million in 2023, then dropped by 1.44% to $142.1 million in 2024, then skyrocketed by 32.18% to $187.8 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Receivables - Net are $187.8 million (Q4 2025), $171.3 million (Q3 2025), and $140.8 million (Q2 2025).